Somanetics To Release Fourth Quarter And Fiscal 2005 Financial Results And Host Conference Call January 31

TROY, Mich., Jan. 10 /PRNewswire-FirstCall/ -- Somanetics Corporation will provide a live audio webcast of its fourth quarter and fiscal 2005 financial results conference call at 11:00 a.m. (ET) Tuesday, January 31, 2006. Somanetics will release its financial results for the quarter and year-end before the opening of the market that morning.

During the webcast, Bruce Barrett, Somanetics' president and chief executive officer, and Bill Iacona, vice president, finance, will discuss the Company's fourth quarter and fiscal 2005 financial results, review corporate highlights and provide a business outlook.

To listen to the webcast, visit the Investor Center page of Somanetics' website at http://www.somanetics.com at least 15 minutes prior to the event's broadcast and click on the "2005 Fiscal Year Conference Call" link. Interested parties unable to listen to the live call may access the archived version of the call on the Investor Center page of Somanetics' website for one year after the call. Windows Media Player is required for access to the webcast, and is available for downloading free of charge on the webcast page.

About the INVOS(R) Cerebral / Somatic Oximeter

The INVOS(R) Cerebral / Somatic Oximeter System is an FDA-cleared cerebral / somatic oximeter that directly and noninvasively measures blood oxygenation changes in regional brain or skeletal muscle tissue. Applicable to adult and pediatric patients, the INVOS System uses visible and near infrared spectroscopy to generate an index of the "regional saturation of oxygen," or rSO2, of the area under the sensor. This rSO2 index data, whether cerebral or somatic, often helps medical professionals detect and correct evolving ischemic problems in surgical or critical care settings, which can improve patient outcomes and reduce the associated cost of care. The current INVOS System technology platform has a nine-year track record among customers and more than 300 clinical documents demonstrating its clinical value.

About Somanetics

Somanetics develops, manufactures and markets medical devices designed to help medical professionals improve patient outcomes in surgery and critical care settings. Somanetics' INVOS System helps address clinical challenges faced by surgeons, anesthesiologists, perfusionists and critical care nurses. The CorRestore System was developed to make Surgical Ventricular Restoration surgery easier for cardiac surgeons and to standardize the operation. These technologies have touched the lives of nearly a half million adult, pediatric and neonatal patients. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Globally, Edwards Lifesciences represents INVOS System products in Japan; and Tyco Healthcare markets INVOS System products in Europe, Canada, the Middle East and South Africa. For more information visit http://www.somanetics.com

Somanetics Corporation

CONTACT: Mary Ann Victor, Vice President, Communications of SomaneticsCorporation, +1-248-689-3050, ext. 204, Fax: +1-248-689-4272

MORE ON THIS TOPIC